Reaction
Oedematous Pancreatitis reporting signals
As of the last recalculation, Oedematous Pancreatitis appears in 551 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is PYRAZINAMIDE (PRR 62.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pyrazinamide | 15 | 62.0 | 62.1 |
| Basiliximab | 18 | 59.7 | 59.8 |
| Rifampin | 17 | 45.4 | 45.4 |
| Isoniazid | 15 | 35.9 | 36.0 |
| Pegaspargase | 9 | 28.2 | 28.2 |
| Insulin Degludec | 11 | 18.0 | 18.1 |
| Cenobamate | 3 | 13.6 | 13.7 |
| Atezolizumab | 11 | 10.9 | 10.9 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 10.0 | 10.0 |